Back to Portfolio
Self-TestingCervical CancerWomen's Health
Invested
2013
Founded
2001
Headquarters
Solna, Sweden
Sector
MedTech
About
Aprovix develops the Qvintip self-sampling device for at-home HPV detection, enabling women to screen for cervical cancer privately and conveniently with clinic-equivalent accuracy. Validated in 25 clinical studies involving over 90,000 women, the ISO 13485 certified device aligns with WHO recommendations for HPV-based screening.